Answers are grounded in this paper and cite their sources.
Laura J Esserman argues that patients are unnecessarily alarmed by calling low risk tumours cancer, but Murali Varma argues that alternative names can also be confusing and better education is the answer
No takes yet. Share an insight, caveat, or question.
Esserman et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: